Utility and interpretation of multiple breath washout in children with cystic fibrosis
- 13 January 2025
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 110 (5) , 214-217
Abstract
Transformative changes in the health of children with cystic fibrosis (CF) mean that more sensitive outcome measures are needed to monitor paediatric CF lung disease. Multiple breath washout (MBW) and its primary readout lung clearance index are gaining increasing traction as an endpoint for clinical trials in the CF space and show promise as a clinical investigation. In this article, we use four clinically based questions to explore what MBW can and cannot (yet) do and highlight some of its strengths and weaknesses as an investigation. We end by discussing how we can increase the utility of MBW as an investigation in children with CF.Keywords
Funding Information
- NIHR Imperial Biomedical Research Centre
This publication has 25 references indexed in Scilit:
- EPS1.03 Establishing the utility of oxygen-enhanced (OE-)MRI as a structural and functional measure of cystic fibrosis lung disease: relationships with physiological and cystic fibrosis outcomesJournal of Cystic Fibrosis, 2023
- A Short extension to multiple breath washout provides additional signal of distal airway disease in people with CF: A pilot studyJournal of Cystic Fibrosis, 2022
- Pulmonary Exacerbations in Adults With Cystic FibrosisChest, 2021
- Lung clearance index-triggered intervention in children with cystic fibrosis – A randomised pilot studyJournal of Cystic Fibrosis, 2020
- Integrating the multiple breath washout test into international multicentre trialsJournal of Cystic Fibrosis, 2020
- Physiologic endpoints for clinical studies for cystic fibrosisJournal of Cystic Fibrosis, 2016
- Lung clearance index: Evidence for use in clinical trials in cystic fibrosisJournal of Cystic Fibrosis, 2014
- Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trialThe Lancet Respiratory Medicine, 2013
- Annual assessment spirometry, plethysmography, and gas transfer in cystic fibrosis: Do they predict death or transplantationPediatric Pulmonology, 2008
- Early intervention and prevention of lung disease in cystic fibrosis: a European consensusJournal of Cystic Fibrosis, 2004